{"id":58107,"name":"TRANSPARENCY-RX CORP.","slug":"transparency-rx-corp","state":"VA","country":"United States of America","description":"Coalition of licensed transparent pharmacy benefit managers","totalSpending":170000,"filings":10,"yearlySpending":[{"year":2023,"income":0},{"year":2024,"income":90000},{"year":2025,"income":80000}],"issues":["HCR"],"firms":["ARENTFOX SCHIFF LLP"],"lobbyists":["DANIEL SJOSTEDT","PHILIP ENGLISH","OLIVER SPURGEON III","KELSEY GRISWOLD-BERGER","KATHERINE KRAMER","BLAKE THELANDER"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Justice, Dept of (DOJ)","Labor, Dept of (DOL)","Health & Human Services, Dept of (HHS)","Office of Management & Budget (OMB)"],"sampleDescriptions":["Pharmacy Benefit Manager reform; transparency in prescription drug markets; prescription drug prices","Pharmacy Benefit Manager reform Transparency in prescription drug markets Prescription drug prices","Pharmacy Benefit Manager reform Transparency in prescription drug markets Prescription drug prices","Pharmacy Benefit Manager reform Transparency in prescription drug markets Prescription drug prices S. 1339 (Pharmacy Benefit Manager Reform Act), all provisions","Pharmacy Benefit Manager reform Transparency in prescription drug markets Prescription drug prices S. 1339 (Pharmacy Benefit Manager Reform Act), all provisions H.R. 6283 (DRUG Act), all provisions"],"years":[2023,2024,2025]}